Xtant Medical

Xtant Announces Fourth Quarter and Year End 2017 Financial Results

BELGRADE, MT / ACCESSWIRE / April 2, 2018 / Xtant™ Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported its financial results for the period ended December 31st, 2017.”2017 represented a significant year for the Company as we completed transformational restructuring activities that were necessary for the future growth of Xtant Medical,” said Carl O’Connell, Chief Executive Officer, ”Our team has worked with focused effort towards repositioning Xtant for operational excellence. We made improvements to our sales structure and channel for long-term success, and continue to stay keenly focused on differ…